Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NK 611

Known as: NK-611, NK611 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND Cancer is a disease characterized by uncontrolled cell growth and proliferation. It has become a major health problem… Expand
2017
2017
Under the effect of a catalytic amount of Au(I) complex, 4-O-(2-cyclopropylethynyl)benzoyl-(epi)-podophyllotoxins, easily… Expand
  • figure 1
  • figure 2
  • figure 3
2012
2012
 
Review
2005
Review
2005
This paper describes extensive research on the activity of more of 100 cytotoxic compounds containing an oxygenated ring in their… Expand
2004
2004
Background: NK611 is a novel podophyllotoxin derivative. Compared with etoposide, NK611 carries a dimethyl-amino group at the D… Expand
  • table 1
  • table 2
2004
2004
SummaryWe have conducted a clinical and pharmacokinetic trial of the novel podophyllotoxin derivative NK611 administered orally… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1996
1996
Abstract NK611 is a novel water-soluble podophyllotoxin derivative that has comparable antitumour activity but higher potency and… Expand
  • figure 1
1995
1995
A simple, reproducible and specific urine assay for the novel epipodophyllotoxin derivative dimethylaminoetoposide (NK611, I) its… Expand
1994
1994
A simple, rapid and reproducible plasma assay for the determination of the novel epipodophyllotoxin derivative… Expand
1993
1993
A simple, selective, reversed phase liquid chromatographic method using a column-switching technique has been developed for the… Expand